Hangzhou Ausainuo Biotechnology

Hangzhou Allsino Chemicals Co., Ltd. (Allsino) is a prominent Contract Development and Manufacturing Organization (CDMO) and a core subsidiary of Sinopep-Allsino Biopharmaceutical Co., Ltd. (SSE: 688076). Established in 2004 and based in Hangzhou, China, the company specializes in the research, development, and large-scale production of Registered Starting Materials (RSMs), GMP intermediates, and Active Pharmaceutical Ingredients (APIs). Allsino is recognized for its expertise in complex small molecule organic synthesis, chiral synthesis, and peptide chemistry, serving global pharmaceutical leaders such as Gilead and Incyte. The company operates a provincial-level biopharmaceutical research institute and extensive GMP-certified manufacturing facilities, supporting drug development from preclinical stages through to commercial supply across therapeutic areas including oncology, metabolic diseases, and antiviral therapy.